Dr Reddy's Laboratories Consolidated Net Profit Declines 86.14% In The March 2026 Quarter

12-May-26   17:52 Hrs IST
Net profit of Dr Reddy's Laboratories declined 86.14% to Rs 220.90 crore in the quarter ended March 2026 as against Rs 1593.30 crore during the previous quarter ended March 2025. Sales declined 11.64% to Rs 7516.20 crore in the quarter ended March 2026 as against Rs 8506.00 crore during the previous quarter ended March 2025.

For the full year,net profit declined 25.80% to Rs 4196.00 crore in the year ended March 2026 as against Rs 5655.10 crore during the previous year ended March 2025. Sales rose 3.19% to Rs 33593.30 crore in the year ended March 2026 as against Rs 32553.50 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales7516.208506.00 -12 33593.3032553.50 3
OPM %5.0923.49 -19.2126.26 -
PBDT756.802459.90 -69 7451.509383.20 -21
PBT199.702005.20 -90 5392.707679.50 -30
NP220.901593.30 -86 4196.005655.10 -26

Powered by Capital Market - Live News

Invest with clarity

on Chola Securities Mobile & Web App.

Stay organised, informed & in control while accessing your portfolio, reports, trading tools and service requests—all in one seamless platform.

Download the app now → The new app is listed as Chola Securities- Prime Access on App store & Google Play.
Also available on Web, Click to explore
Trading App Screen
We are hiring! Check out open positions and send your CV to csecrecruit@chola.murugappa.com
View Careers
Pre-Apply for IPOs
Chola Securities App
Install
🌐
Stay on Web